Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F Fuligni
Low-Dose Lenalidomide Plus Cytarabine Induce Complete Remission That Can Be Predicted by Genetic Profiling in Elderly Acute Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Cytarabine Dose for Acute Myeloid Leukemia
New England Journal of Medicine
Medicine
Randomized, Phase IIb Study of Low-Dose Cytarabine and Lintuzumab Versus Low-Dose Cytarabine and Placebo in Older Adults With Untreated Acute Myeloid Leukemia
Haematologica
Hematology
Persistent Molecular Remission of Refractory Acute Myeloid Leukemia With Inv(16)(p13.1q22) in an Elderly Patient Induced by Cytarabine Ocfosfate Hydrate
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902
Leukemia Research
Cancer Research
Oncology
Hematology
Therapy-Related Acute Non-Lymphocytic Leukemia(M2) With 7;11 Chromosome Translocation Induced Into Complete Remission by Low Dose Cytosine Arabinoside and Cytarabine Ocfosfate Therapy.
Japanese Journal of Geriatrics
Gerontology
Geriatrics
A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Venetoclax Plus Decitabine Induced Complete Remission With Molecular Response in Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplantation
American Journal of Hematology
Hematology
